The World Health Organization defines Telehealth as the delivery of health care services, where patients and providers are […], Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Get Guardant Health, Inc. (GH) exclusive data and insights at your fingertips with intuitive visualizations. Guardant Health, Inc. (GH) See Guardant Health, Inc. (GH) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12) * AbbVie Inc (NYSE: ABBV) * AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) * Aldeyra Therapeutics Inc (NASDAQ: ALDX) * Alkermes Plc (NASDAQ: ALKS) * AtriCure Inc. (NASDAQ: ATRC) * Bioanalytical Systems, Inc. (NASDAQ: BASI) * BIOLASE Inc (NASDAQ: BIOL) (announced an agreement to expand laser adoption and hands-on training programs in targeted geographies) * CareDx Inc (NASDAQ: CDNA) * Celsius Holdings, Inc. (NASDAQ: CELH) * DermTech Inc (NASDAQ: DMTK) * Dyne Therapeutics Inc (NASDAQ: DYN) * Edap Tms SA (NASDAQ: EDAP) * Evelo Biosciences Inc (NASDAQ: EVLO) * EXACT Sciences Corporation (NASDAQ: EXAS) * Eyenovia Inc (NASDAQ: EYEN) * Genetron Holdings Ltd - ADR (NASDAQ: GTH) * Guardant Health Inc (NASDAQ: GH) (reacted to presentation at the JPMorgan Healthcare Conference) * Intra-Cellular Therapies Inc (NASDAQ: ITCI) * Kaleido Biosciences Inc (NASDAQ: KLDO) * Laboratory Corp. of America Holdings (NYSE: LH) * Merus NV (NASDAQ: MRUS) (announced presentation of Phase 1 data for MCLA-158 in metastatic colorectal cancer) * OncoSec Medical Inc (NASDAQ: ONCS) * Pacira Biosciences Inc (NASDAQ: PCRX) * PRA Health Sciences Inc (NASDAQ: PRAH) * Provention Bio Inc (NASDAQ: PRVB) * SAGE Therapeutics Inc (NASDAQ: SAGE) * Supernus Pharmaceuticals Inc (NASDAQ: SUPN) * Syneos Health Inc (NASDAQ: SYNH) * Travere Therapeutics Inc (NASDAQ: TVTX) * Vericel Corp (NASDAQ: VCEL) * X T L Biopharmaceuticals Ltd (NASDAQ: XTLB) * Zai Lab Ltd - ADR (NASDAQ: ZLAB)Down In The Dumps (Biotech Stocks Hitting 52-week Lows Jan. 12) * Fusion Pharmaceuticals Inc (NASDAQ: FUSN) * Lexaria Bioscience Corp. (LXRP) (the company's shares uplisted to Nasdaq and it also announced a $9.6 million public offering) * Viveve Medical Inc (NASDAQ: VIVE)Stocks In Focus Acorda to Sell Parkinson's Disease Drug Manufacturing Facility, Reduce 16% of Workforce Acorda Therapeutics Inc (NASDAQ: ACOR) announced a definitive agreement to sell its Inbrija manufacturing operations in Chelsea, Massachusetts to Catalent Inc (NYSE: CTLT) for $80 million in cash.In connection with the sale, Acorda and Catalent have entered into a long-term global supply agreement under which Catalent will manufacture and package Inbrija for Acorda. 154.57 +11.70 (+8.19%) At close: 4:00PM EST. Descubre los ingresos, los gastos y los beneficios o las pérdidas en el último año fiscal. Get the detailed quarterly/annual income statement for Guardant Health, Inc. (GH). Lee los debates de acciones de Guardant Health, Inc. (GH) más recientes en el foro de Yahoo Finanzas. Yahoo ist Teil von Verizon Media. For the full year of 2020, the company expects to report revenues above the high-end of its revenue guidance range of $7.8 billion-$8 billion.Analysts, on average, estimate expect revenues of $2.12 billion for the fourth quarter and $7.94 billion for the full year.The company also guided to strong adjusted EBITDA.In after-hours trading, the stock rose 5.67% to $24.80.Neuronetics Inc (NASDAQ: STIM) preannounced fourth-quarter revenues of $15 million to $15.5 million, ahead of the guidance of $13 million and $13.5 million. Find out the revenue, expenses and profit or loss over the last fiscal year. Conquering Cancer with Data. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the upcoming 39th Annual J.P. Morgan Virtual Healthcare Conference. Consigue el estado de ingresos detallado trimestral o anual de Guardant Health, Inc. (GH). Find out the revenue, expenses and profit or loss over the last fiscal year. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. Find the latest Guardant Health, Inc. (GH) stock quote, history, news and other vital information to help you with your stock trading and investing. Guardant Health, Inc. (Nasdaq: GH), along with leading academic institutions and pharmaceutical companies, will present data highlighting the clinical utility of Guardant Health’s proprietary blood tests to make a meaningful impact on patient care at the upcoming virtual 2021 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium being held January 15-17, 2021. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the upcoming 39th Annual J.P. Morgan Virtual Healthcare Conference. We believe the market opportunity for Guardant’s tests could be greater than $35 billion in the U.S. alone. Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering. See the company profile for Guardant Health, Inc. (GH), including business summary, industry/sector information, number of employees, corporate governance, key executives and salary information. Find the latest Guardant Health, Inc. (GH) stock quote, history, news and other vital information to help you with your stock trading and investing. Dies geschieht in Ihren Datenschutzeinstellungen. Discover historical prices for GH stock on Yahoo Finance. View daily, weekly or monthly formats back to when Guardant Health, Inc. stock was issued. NasdaqGS - NasdaqGS Real Time Price. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. Find the latest Guardion Health Sciences, Inc. (GHSI) stock quote, history, news and other vital information to help you with your stock trading and investing. COVID-19 diagnostic expands testing supply, protects the continuity of essential cancer work at Guardant Health, and helps with reopening at Delaware State UniversityREDWOOD CITY, Calif., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. … All rights reserved. As part of the deal, Catalent will absorb all Acorda employees who work at the Chelsea facility, and certain Acorda employees at the company's Waltham, Massachusetts facility.Acorda also announced a corporate restructuring to reduce costs and focus its resources on Imbrija. Sie können Ihre Einstellungen jederzeit ändern. Descubre las transacciones más recientes de las personas con información privilegiada de Guardant Health, Inc. (GH). Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering. Discover historical prices for GH stock on Yahoo Finance. Daten über Ihr Gerät und Ihre Internetverbindung, darunter Ihre IP-Adresse, Such- und Browsingaktivität bei Ihrer Nutzung der Websites und Apps von Verizon Media. See Guardant Health, Inc. (GH) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. This year has been both a good one and a bad one for the healthcare sector. Dazu gehört der Widerspruch gegen die Verarbeitung Ihrer Daten durch Partner für deren berechtigte Interessen. See the company profile for Guardant Health, Inc. (GH), including business summary, industry/sector information, number of employees, corporate governance, key executives and salary information. Get the detailed quarterly/annual income statement for Guardant Health, Inc. (GH). Damit Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie bitte 'Ich stimme zu.' Share your opinion and gain insight from other stock traders and investors. Guardant Health, Inc. (GH) Add to watchlist. aus oder wählen Sie 'Einstellungen verwalten', um weitere Informationen zu erhalten und eine Auswahl zu treffen. Currency in USD, Trade prices are not sourced from all markets. We’re developing blood tests for early detection in high-risk populations and recurrence monitoring in … The NCCN Clinical Practice Guidelines in Oncology for cutaneous melanoma recognize the use of noninvasive genomic patch testing to help guide biopsy decisions for cutaneous melanoma.The stock gained 12.46% to $41.61 in after-hours trading.Amgen In-licenses Autoimmune Disorder Programs For Over $240M Amgen, Inc. (NASDAQ: AMGN) executed a license and collaboration agreement with EVOQ Therapeutics for the discovery and development of novel drugs for autoimmune disorders. Sparsentan is an investigational product candidate currently being evaluated for the treatment of IgAN, as well as focal segmental glomerulosclerosis in pivotal Phase 3 clinical trials that are expected to report topline data from interim proteinuria assessments in 2021.DermTech's Non-invasive Melanoma Genomic Test Recommended by National Comprehensive Cancer Network DermTech said non-invasive genomic patch testing for melanoma, like DermTech's pigmented lesion assay, has received a recommendation from the National Comprehensive Cancer Network. For the full year, revenues are estimated between $48.7 million and $49.2 million. View the basic GH option chain and compare options of Guardant Health, Inc. on Yahoo Finance. Descubre el total de acciones que las personas con información privilegiada tienen, han adquirido y han vendido. © 2021 Verizon Media. All rights reserved. Discover historical prices for GH.MX stock on Yahoo Finance. Get the latest insider transactions for Guardant Health, Inc. (GH). Find the latest Guardant Health, Inc. (GH) stock discussions in Yahoo Finance's forum. Für nähere Informationen zur Nutzung Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie. Get the latest Guardant Health, Inc. (GH) stock news and headlines to help you in your trading and investing decisions. Wir und unsere Partner nutzen Cookies und ähnliche Technik, um Daten auf Ihrem Gerät zu speichern und/oder darauf zuzugreifen, für folgende Zwecke: um personalisierte Werbung und Inhalte zu zeigen, zur Messung von Anzeigen und Inhalten, um mehr über die Zielgruppe zu erfahren sowie für die Entwicklung von Produkten. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. 提供10年額外固定收入,投保兼享稅務優惠,每年慳稅高達港幣10,200元,立即網上投保!, In this article, we present to you the 12 best telemedicine stocks to buy now according to hedge funds. Guardant Health Receives FDA Emergency Use Authorization for its Guardant-19 Next Generation Sequencing-Based COVID-19 Test. See Guardant Health, Inc. (GH) Environment, Social and Governance Ratings to help you in your stock buying decisions. Find out the total of … All of the shares to be sold in the offering are to be sold by the company.The stock fell 10.03% to $17.50 in after-hours trading.Affimed NV (NASDAQ: AFMD) announced the commencement of an underwritten public offering of its common shares. In addition to the associates who will transition to Catalent, Acorda is reducing its combined Ardsley, Waltham and field headcount by approximately 16% through a reduction in force.Acorda also said it entered into an at-the-market offering agreement with H.C. Wainwright & Co., for offering common stock having an aggregate value of up to $15.25 million.Acorda shares jumped 59.91% to $6.78 in premarket trading Wednesday.Morphosys, Incyte Announce Canadian Regulatory Submission For Blood Cancer Combo Treatment Morphosys Ag (NASDAQ: MOR) and Incyte Corporation (NASDAQ: INCY) said Health Canada has accepted the new drug submission for tafasitamab, an anti-CD19 antibody, in combination with Bristol-Myers Squibb Co's (NYSE: BMY) Revlimid for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.Incyte has exclusive commercialization rights for tafasitamab outside of the U.S. and, if approved, Incyte will hold the marketing authorization for tafasitamab in Canada.Travere Gets Orphan Drug Designation For Sparsentan In Rare Kidney Disorder Travere announced that the FDA has granted orphan drug designation to sparsentan for the treatment of IgA nephropathy, a rare kidney disorder that causes end-stage kidney disease. Guardant Health’s management is scheduled to present on Monday, January 11 at 7:50 a.m. Pacific Time / 10:50 a.m. Eastern Time. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering, the company added.In the after-hours session, the stock slipped 7.85% to $6.10.See more from Benzinga * Click here for options trades from Benzinga * The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue * The Week Ahead In Biotech (Jan 10-16): Expect Stocks To Move As J.P. Morgan Healthcare Conference Kicks Off(C) 2021 Benzinga.com. The consensus estimates call for revenues of $13.24 for the fourth quarter and $46.93 for the full year.The stock rallied 14.82% to $13.40 in after-hours trading.Clearpoint Neuro Inc (NASDAQ: CLPT) preannounced above-consensus revenues for the fourth quarter and full year.The stock was up 3.43% to $15.99 in after-hours trading.Offerings Provention Bio Inc (NASDAQ: PRVB) said it has commenced an underwritten public offering of 6 million shares of its common stock. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). How Guardant Health is supporting cancer care during the pandemic. View daily, weekly … Understand the cash flow statement for Guardant Health, Inc. (GH), learn where the money comes from and how the company spends it. Benzinga does not provide investment advice. If you’re in a hurry you can skip ahead to the 5 best telemedicine stocks to buy now. Under the terms of the agreement, Amgen and EVOQ will collaborate on preclinical development and Amgen will be responsible for clinical development and commercialization.In exchange for exclusive rights to selected autoimmune programs, Amgen will make upfront and milestone payments potentially totaling more than $240 million, as well as pay royalties on sales of resulting therapies.Mersana Shares Gain On Insider Buying Mersana Therapeutics Inc (NASDAQ: MRSN) shares gained after a filing with the SEC revealed that Andrew Hack, a member of the board, bought 250,000 shares in the company.The stock added 7.34% to $19.45 in after-hours trading.Preannouncements Ahead of the presentation at the JPMorgan Health Conference Bausch Health Companies Inc (NYSE: BHC) said it expects fourth-quarter revenues to be greater than $2.20 billion. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Vall d’Hebron Institute of Oncology (VHIO), one of Europe’s leading cancer research organizations, have agreed to enter into a partnership to establish in-house liquid biopsy testing services, using Guardant Health… Make 2021 your best (financial) year yet with Yahoo Finance's free daily newsletter. Back. View daily, weekly or monthly format back to when GUARDANT HEALTH INC stock was issued. Consulta el perfil de empresa de Guardant Health, Inc. (GH), que incluye el resumen de negocio, la información del sector o industria, el número de empleados, el resumen de negocio, el gobierno corporativo, los principales ejecutivos y su remuneración. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Get the latest Guardant Health, Inc. (GH) stock news and headlines to help you in your trading and investment decisions. Comparte tu opinión y conoce los puntos de vista de otros corredores de bolsa e inversores. The latest economy, property, and money news, tips and advice: straight to your inbox. Find out all the key statistics for Guardant Health, Inc. (GH), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. The recommendation indicates that there is uniform NCCN consensus that the intervention is appropriate.